04 / Prevent and cure cancer


Biotechnology that leverages the immune system and other emerging platforms could make huge strides in the fight against cancer.

Why it matters

Cancer is the second leading cause of death globally, responsible for over 9 million deaths worldwide per year. In developed nations, nearly 1 in 2 adults risk developing cancer. Current diagnostic methods are insufficient to reliably detect many cancers early enough for successful therapy, let alone prevention in the first place.

What if every woman had access to a breast cancer vaccine, preventing millions of mastectomies and deaths? What if cell and gene therapies could cure the most resistant forms of cancer, like brain tumors? Today’s most effective treatments are customized based on the patient’s own cells, making them costly and time-consuming, and they are limited to certain cancer types only. In the future, the development of scalable, off-the-shelf solutions could democratize next-generation cancer immunotherapies and save millions of lives.

Category

health

Companies addressing this leap

  • khloris biosciences health logo
  • dewpoint health logo
  • metagenomi health logo
  • immunitas therapeutics health logo
  • vesigen therapeutics health logo
  • kojin health logo
  • triumvira therapeutics health logo
  • futu health logo
  • gandeeva therapeutics health logo
  • grobiosciences health logo
  • dekabiosciences health logo
  • indapta therapeutics health logo
  • affini-t health logo
  • capstan health logo
  • nextpoint therapeutics health logo
  • paratus health logo
  • casebia therapeutics health logo
  • century therapeutics logo
  • pyxis oncology logo
  • arvin
  • recursion logo
  • senti bio health logo
  • boundless bio health logo

It’s our responsibility to engage society

We collaborate with partners worldwide to engage others in industry, academia, leaders, and civil society in this critical dialogue.